Please assess the completion status of the following clinical trial:

Trial Title: The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients of both sexes (women after menopause, women of child-bearing age after sterilization or if practicing reliable contraception)~* Type 2 DM requiring insulin therapy after failure of maximal oral antidiabetic treatment (glycosylated Hb \> 7.5%) and need for exogenous insulin. (No concomitant use of oral antidiabetic agents)~* Being ambulatory~* Age: 30 to 80 years~* Proven absence of Islet Antibodies, if QI \< 28 kg/m2~* Insulin therapy 4 times daily (21), or insulin therapy 2 times daily using insulin 'mixtures' (rapidly and slowly acting)~* Standard dietary prescription by the dietician~* Absence of keto-acidosis~* Informed consent~Exclusion Criteria:~* Congestive heart failure, NYHA-classes III or IV~* Cardiac failure and/or myocardial infarction in the last four months before enrolment~* Other severe organic / systemic disease~* Metformin-induced lactic-acidosis~* Intolerance to metformin hydrochloride~* Renal disease or renal dysfunction~* Hypoxic states~* Severe hepatic dysfunction~* Excessive alcohol intake, acute or chronic~* Acute or chronic metabolic acidosis

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).